Alteration of tumor suppressor BMP5 in sporadic colorectal cancer: a genomic and transcriptomic profiling based study

[1]  C. Lindskog,et al.  A pathology atlas of the human cancer transcriptome , 2017, Science.

[2]  Hongjuan He,et al.  The screening of the functional microRNA binding site SNPs in sporadic colorectal cancer genes , 2017, Cancer biology & therapy.

[3]  Limei Liu,et al.  MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer. , 2016, Cancer research.

[4]  Hongjuan He,et al.  Decreased level of RASSF6 in sporadic colorectal cancer and its anti-tumor effects both in vitro and in vivo , 2016, Oncotarget.

[5]  Xuemei Lu,et al.  Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution , 2015, Proceedings of the National Academy of Sciences.

[6]  William M. Grady,et al.  Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. , 2015, Gastroenterology.

[7]  J. Carethers,et al.  Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer. , 2015, Gastroenterology.

[8]  D. Medici,et al.  Signaling mechanisms of the epithelial-mesenchymal transition , 2014, Science Signaling.

[9]  G. McVean,et al.  Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications , 2014, Nature Genetics.

[10]  Tom R. Gaunt,et al.  Predicting the functional consequences of cancer-associated amino acid substitutions , 2013, Bioinform..

[11]  D. Seldin,et al.  Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by Blimp-1-dependent repression of BMP-5. , 2012, Cancer research.

[12]  Hugo Y. K. Lam,et al.  Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes , 2012, Cell.

[13]  Joseph K. Pickrell,et al.  A Systematic Survey of Loss-of-Function Variants in Human Protein-Coding Genes , 2012, Science.

[14]  Stephen J. Salipante,et al.  Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers , 2011, Proceedings of the National Academy of Sciences.

[15]  A. Kallioniemi,et al.  Bone morphogenetic protein -4 and -5 in pancreatic cancer--novel bidirectional players. , 2011, Experimental cell research.

[16]  Mingyao Li,et al.  Widespread RNA and DNA Sequence Differences in the Human Transcriptome , 2011, Science.

[17]  Yong-mei Zhu,et al.  Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia , 2011, Nature Genetics.

[18]  P. A. Futreal,et al.  Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma , 2010, Nature.

[19]  Emily H Turner,et al.  Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome , 2010, Nature Genetics.

[20]  I. Cuthill,et al.  Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .

[21]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[22]  P. Shannon,et al.  Exome sequencing identifies the cause of a Mendelian disorder , 2009, Nature Genetics.

[23]  Ken Chen,et al.  Recurring mutations found by sequencing an acute myeloid leukemia genome. , 2009, The New England journal of medicine.

[24]  F. Beuschlein,et al.  Bone morphogenetic proteins 2 and 5 are down-regulated in adrenocortical carcinoma and modulate adrenal cell proliferation and steroidogenesis. , 2009, Cancer research.

[25]  D. Nelson,et al.  Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication , 2005, Virology Journal.

[26]  A. Waage,et al.  Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells , 2004, Oncogene.

[27]  Long-Cheng Li,et al.  MethPrimer: designing primers for methylation PCRs , 2002, Bioinform..

[28]  A. Børresen-Dale,et al.  Epithelial and Mesenchymal Cell Biology Epithelial-Stromal Interaction 1 ( EPSTI 1 ) Substitutes for Peritumoral Fibroblasts in the Tumor Microenvironment , 2010 .